Stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of liver metastases in oligometastatic patients: initial clinical experience
Gamze Ugurluer, Teuta Zoto Mustafayev, Gorkem Gungor, Banu Atalar, Ufuk Abacioglu, Meric Sengoz, Fulya Agaoglu, Gokhan Demir, Enis Ozyar
Radiat Oncol J. 2021;39(1):33-40.   Published online 2021 Mar 26     DOI: https://doi.org/10.3857/roj.2020.00976
Citations to this article as recorded by Crossref logo
Stereotactic body radiation therapy for liver metastases in oligometastatic disease
N. Jaksic, A. Modesto, N. Meillan, A. Bordron, M. Michalet, O. Riou, A. Lisbona, F. Huguet
Cancer/Radiothérapie.2024; 28(1): 75.     CrossRef
The Use of MR-Guided Radiation Therapy for Liver Cancer
Sabrina Prime, Joshua P. Schiff, Ali Hosni, Teodor Stanescu, Laura A. Dawson, Lauren E. Henke
Seminars in Radiation Oncology.2024; 34(1): 36.     CrossRef
Interobserver variation in tumor delineation of liver metastases using Magnetic Resonance Imaging
Julia E. Peltenburg, Ali Hosni, Rana Bahij, Simon Boeke, Pètra M. Braam, William A. Hall, Martijn P.W. Intven, Luca Nicosia, Jan-Jakob Sonke, Marnix Witte, Marlies E. Nowee, Tomas Janssen
Physics and Imaging in Radiation Oncology.2024; 30: 100592.     CrossRef
Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States – Understanding the transition to adaptive, ultra-hypofractionated treatments
Michael D. Chuong, Mary Ann Clark, Lauren E. Henke, Amar U. Kishan, Lorraine Portelance, Parag J. Parikh, Michael F. Bassetti, Himanshu Nagar, Stephen A. Rosenberg, Minesh P. Mehta, Tamer Refaat, Justin M. Rineer, Adam Smith, Steven Seung, Bassem I. Zaki,
Clinical and Translational Radiation Oncology.2023; 38: 161.     CrossRef
A single high-dose irradiation changes accumulation of methotrexate and gene expression levels of SLC and ABC transporters in cancer cells
Kakeru Sato, Tatsuya Seki, Asuka Mizutani, Yuka Muranaka, Shiho Hirota, Kodai Nishi, Kana Yamazaki, Ryuichi Nishii, Takeo Nakanishi, Ikumi Tamai, Keiichi Kawai, Masato Kobayashi
Frontiers in Pharmacology.2023;[Epub]     CrossRef
Local control and patient reported outcomes after online MR guided stereotactic body radiotherapy of liver metastases
Laura Uder, Marcel Nachbar, Sarah Butzer, Jessica Boldt, Sabrina Baumeister, Michael Bitzer, Alfred Königsrainer, Thomas Seufferlein, Rüdiger Hoffmann, Sergios Gatidis, Konstantin Nikolaou, Daniel Zips, Daniela Thorwarth, Cihan Gani, Simon Boeke
Frontiers in Oncology.2023;[Epub]     CrossRef
MRI-LINAC: A transformative technology in radiation oncology
John Ng, Fabiana Gregucci, Ryan T. Pennell, Himanshu Nagar, Encouse B. Golden, Jonathan P. S. Knisely, Nicholas J. Sanfilippo, Silvia C. Formenti
Frontiers in Oncology.2023;[Epub]     CrossRef
Stereotactic MR-Guided Radiotherapy for Liver Metastases: First Results of the Montpellier Prospective Registry Study
Karl Bordeau, Morgan Michalet, Aïcha Keskes, Simon Valdenaire, Pierre Debuire, Marie Cantaloube, Morgane Cabaillé, William Jacot, Roxana Draghici, Sylvain Demontoy, Xavier Quantin, Marc Ychou, Eric Assenat, Thibault Mazard, Ludovic Gauthier, Marie Dupuy,
Journal of Clinical Medicine.2023; 12(3): 1183.     CrossRef
The role of adaptive planning in margin-reduced, MRI-guided stereotactic body radiotherapy to the prostate bed following radical prostatectomy: Post-hoc analysis of a phase II clinical trial
John Nikitas, Lauren M. Smith, Yu Gao, Ting Martin Ma, Ankush Sachdeva, Stephanie M. Yoon, Tommy Jiang, Daniel A. Low, Leslie K. Ballas, Michael L. Steinberg, Minsong Cao, Amar U. Kishan
Radiotherapy and Oncology.2023; 183: 109631.     CrossRef
Magnetic resonance-guided stereotactic body radiation therapy (MRgSBRT) for oligometastatic patients: a single-center experience
Giuditta Chiloiro, Luca Boldrini, Angela Romano, Lorenzo Placidi, Huong Elena Tran, Matteo Nardini, Mariangela Massaccesi, Francesco Cellini, Luca Indovina, Maria Antonietta Gambacorta
La radiologia medica.2023; 128(5): 619.     CrossRef
Clinical outcomes of patients with unresectable primary liver cancer treated with MR-guided stereotactic body radiation Therapy: A Six-Year experience
Re-I Chin, Joshua P. Schiff, Anirudh Bommireddy, Kylie H. Kang, Neal Andruska, Alexander T. Price, Olga L. Green, Yi Huang, Kevin Korenblat, Parag J Parikh, Jefferey Olsen, Pamela P. Samson, Lauren E. Henke, Hyun Kim, Shahed N. Badiyan
Clinical and Translational Radiation Oncology.2023; 41: 100627.     CrossRef
Clinical Applications of Magnetic Resonance-Guided Radiotherapy: A Narrative Review
Colton Ladbury, Arya Amini, Amanda Schwer, An Liu, Terence Williams, Percy Lee
Cancers.2023; 15(11): 2916.     CrossRef
Local Control Following Stereotactic Body Radiation Therapy for Liver Oligometastases: Lessons from a Quarter Century
Sara Mheid, Stefan Allen, Sylvia S. W. Ng, William A. Hall, Nina N. Sanford, Todd A. Aguilera, Ahmed M. Elamir, Rana Bahij, Martijn P. W. Intven, Ganesh Radhakrishna, Issa Mohamad, Jeremy De Leon, Hendrick Tan, Shirley Lewis, Cihan Gani, Teo Stanecu, Vero
Current Oncology.2023; 30(10): 9230.     CrossRef
Degree of reduction in normal liver complication probability from free-breathing to breath-hold liver SBRT: a dose-escalation strategy using radiation dose-volume effect
Deepak Thaper, Hanuman P Yadav, Deepti Sharma, Rose Kamal, Gaganpreet Singh, Arun S. Oinam, Vivek Kumar
Biomedical Physics & Engineering Express.2022; 8(1): 015020.     CrossRef
MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial
P. Hoegen, K. S. Zhang, E. Tonndorf-Martini, F. Weykamp, S. Regnery, P. Naumann, K. Lang, J. Ristau, S. A. Körber, C. Dreher, C. Buchele, C. Rippke, C. K. Renkamp, K. M. Paul, L. König, C. Büsch, J. Krisam, O. Sedlaczek, H.-P. Schlemmer, M. Niyazi, S. Cor
Radiation Oncology.2022;[Epub]     CrossRef
Compact bunker shielding assessment for 1.5 T MR-Linac
Jiwon Sung, Yeonho Choi, Jun Won Kim, Ik Jae Lee, Ho Lee
Scientific Reports.2022;[Epub]     CrossRef
Multi-Institutional Outcomes of Stereotactic Magnetic Resonance Image Guided Adaptive Radiation Therapy With a Median Biologically Effective Dose of 100 Gy10 for Non-bone Oligometastases
Tugce Kutuk, Robert Herrera, Teuta Z. Mustafayev, Gorkem Gungor, Gamze Ugurluer, Banu Atalar, Rupesh Kotecha, Matthew D. Hall, Muni Rubens, Kathryn E. Mittauer, Jessika A. Contreras, James McCulloch, Noah S. Kalman, Diane Alvarez, Tino Romaguera, Alonso N
Advances in Radiation Oncology.2022; 7(6): 100978.     CrossRef
MR-guided beam gating: Residual motion, gating efficiency and dose reconstruction for stereotactic treatments of the liver and lung
Stefanie Ehrbar, Sarah Braga Käser, Madalyne Chamberlain, Jérôme Krayenbühl, Lotte Wilke, Michael Mayinger, Helena Garcia Schüler, Matthias Guckenberger, Nicolaus Andratschke, Stephanie Tanadini-Lang
Radiotherapy and Oncology.2022; 174: 101.     CrossRef
Que faut-il pour faire de la radiothérapie adaptative « online » ?
G. Delpon, A. Barateau, A. Beneux, I. Bessières, I. Latorzeff, J. Welmant, A. Tallet
Cancer/Radiothérapie.2022; 26(6-7): 794.     CrossRef
Clinical adoption patterns of 0.35 Tesla MR-guided radiation therapy in Europe and Asia
Berend J. Slotman, Mary Ann Clark, Enis Özyar, Myungsoo Kim, Jun Itami, Agnès Tallet, Jürgen Debus, Raphael Pfeffer, PierCarlo Gentile, Yukihiro Hama, Nicolaus Andratschke, Olivier Riou, Philip Camilleri, Claus Belka, Magali Quivrin, BoKyong Kim, Anders P
Radiation Oncology.2022;[Epub]     CrossRef
The future of MRI in radiation therapy: Challenges and opportunities for the MR community
Rosie J. Goodburn, Marielle E. P. Philippens, Thierry L. Lefebvre, Aly Khalifa, Tom Bruijnen, Joshua N. Freedman, David E. J. Waddington, Eyesha Younus, Eric Aliotta, Gabriele Meliadò, Teo Stanescu, Wajiha Bano, Ali Fatemi‐Ardekani, Andreas Wetscherek, Uw
Magnetic Resonance in Medicine.2022; 88(6): 2592.     CrossRef
Finding Resonance: Using MRI to Improve the Care of Oligometastatic Disease
Lisa Singer, Jessica Scholey
International Journal of Radiation Oncology*Biology*Physics.2022; 114(5): 936.     CrossRef
MRI-guided Radiotherapy (MRgRT) for Treatment of Oligometastases: Review of Clinical Applications and Challenges
Indrin J. Chetty, Anthony J. Doemer, Jennifer L. Dolan, Joshua P. Kim, Justine M. Cunningham, Jadranka Dragovic, Aharon Feldman, Eleanor M. Walker, Mohamed Elshaikh, Khaled Adil, Benjamin Movsas, Parag J. Parikh
International Journal of Radiation Oncology*Biology*Physics.2022; 114(5): 950.     CrossRef
Clinical Efficacy of Hypofractionated Proton Beam Therapy for Intrahepatic Cholangiocarcinoma
Tae Hyun Kim, Sang Myung Woo, Woo Jin Lee, Jung Won Chun, Yu Ri Cho, Bo Hyun Kim, Young-Hwan Koh, Sang Soo Kim, Eun Sang Oh, Do Yeul Lee, Sung Uk Lee, Yang-Gun Suh, Sung Ho Moon, Joong-Won Park
Cancers.2022; 14(22): 5561.     CrossRef
Optimized Adaptive Radiotherapy with Individualized Plan Library for Muscle-Invasive Bladder Cancer Using Internal Target Volume Generation
Yoon Young Jo, Ji Woon Yea, Jaehyeon Park, Se An Oh, Jae Won Park
Cancers.2022; 14(19): 4674.     CrossRef
Assessment of semi-automated stereotactic treatment planning for online adaptive radiotherapy in ethos
Mikel Byrne, Ben Archibald-Heeren, Yunfei Hu, Peter Greer, Suhuai Luo, Trent Aland
Medical Dosimetry.2022; 47(4): 342.     CrossRef
Dosimetric Benefit of Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver Metastases
Fabian Weykamp, Efthimios Katsigiannopulos, Lars Piskorski, Sebastian Regnery, Philipp Hoegen, Jonas Ristau, C. Katharina Renkamp, Jakob Liermann, Tobias Forster, Kristin Lang, Laila König, Carolin Rippke, Carolin Buchele, Jürgen Debus, Sebastian Klüter,
Cancers.2022; 14(24): 6041.     CrossRef